Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease ... a plasma cell cancer, could potentially be repurposed to treat IPF.

Lung cancer is a disease in which cancerous cells form in the tissues around and inside the lung. There are various types of this disease. Non-small cell lung cancer (NSCLC) is a disease where cancer ...

Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

With a unique mechanism of action, decades of data supporting its safe use, and preclinical proof of effectiveness, the drug is set to help patients with non-small-cell lung cancer (NSCLC ...

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research. This optimism comes in the wake of the Food and Drug Administration’s ...